BNC KOREA, Inc. (KOSDAQ:256840)
South Korea · Delayed Price · Currency is KRW 3,225.00
+25.00 (0.78%)
May 21, 2026, 3:30 PM KST
BNC KOREA Revenue
In the year 2025, BNC KOREA had annual revenue of 95.90B KRW with 7.47% growth. BNC KOREA had revenue of 23.57B in the quarter ending December 31, 2025, a decrease of -8.58%.
Revenue
95.90B
Revenue Growth
+7.47%
P/S Ratio
2.28
Revenue / Employee
383.60M
Employees
n/a
Market Cap
218.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 95.90B | 6.67B | 7.47% |
| Dec 31, 2024 | 89.23B | 8.23B | 10.16% |
| Dec 31, 2023 | 81.00B | 38.69B | 91.47% |
| Dec 31, 2022 | 42.30B | 17.05B | 67.55% |
| Dec 31, 2021 | 25.25B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chong Kun Dang Holdings | 959.01B |
| Suheung | 722.31B |
| Daewon Pharmaceutical | 605.43B |
| Jeil Pharmaceutical Co.,Ltd | 567.24B |
| Samjin Pharmaceuticals | 274.03B |
| Whan In Pharm | 255.21B |
| HLB Pharmaceutical | 205.58B |
| Boditech Med | 162.09B |